Haga Bioscience, a Stockholm-based spatial biology startup, has secured $2.3 million (SEK 20.9 million) in an oversubscribed seed funding round from investors including Almi Invest, Life Science Invest, SU Ventures, and a group of private investors and life sciences industry veterans. The company is developing technologies that aim to address a key challenge in spatial biology: validating RNA biomarkers identified through discovery research across larger clinical cohorts. The funding will be used to support product development, commercialization activities, and partnerships with academic and industry organizations. Haga Bioscience’s technology is based on in situ hybridization methods developed by its founding team and is designed...
Læs hele artiklen hos kilden.
Kommentarer (0)
Ingen kommentarer ennå. Bli den første til å kommentere!